COVID-19 in Individuals Treated With Long-Term Hydroxychloroquine: A Propensity Score-Matched Analysis of Cicatricial Alopecia Patients

Katharina S. Shaw, Lu Yin, Jinal K. Shah, Rachel A. Sally, Katerina S. Svigos, Prince U. Adotama, Hsiao Han Tuan, Jerry Shapiro, Rebecca A. Betensky, Kristen I. Lo Siccoa

Research output: Contribution to journalArticlepeer-review

Abstract

Early in the COVID-19 pandemic, anti-malarial agent hydroxychloroquine (HCQ) was touted as a potentially effective COVID-19 treatment due to its purported antiinflammatory and antiviral effects.

Original languageEnglish (US)
Pages (from-to)914-916
Number of pages3
JournalJournal of Drugs in Dermatology
Volume20
Issue number8
DOIs
StatePublished - Aug 1 2021

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'COVID-19 in Individuals Treated With Long-Term Hydroxychloroquine: A Propensity Score-Matched Analysis of Cicatricial Alopecia Patients'. Together they form a unique fingerprint.

Cite this